M. Dikov

发表

Adenosine receptors in regulation of dendritic cell differentiation and function.

D. Carbone, I. Biaggioni, M. Blackburn, 2008, Blood.

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings

D. Carbone, M. Dikov, A. Shanker, 2020, Frontiers in Immunology.

Multifunctional Nanoparticulate Polyelectrolyte Complexes

Sean M. Hartig, A. Prokop, J. Davidson, 2007, Pharmaceutical Research.

Acknowledgement

D. Busch, H. Einsele, M. Dhodapkar, 1987, Hearing Research.

Innate-Adaptive Immune Crosstalk

M. Mishra, M. Dikov, R. Uzhachenko, 2015, Journal of immunology research.

Role of JunB in Adenosine A2B Receptor–Mediated Vascular Endothelial Growth Factor Production

I. Biaggioni, A. Biktasova, Sergey Ryzhov, 2014, Molecular Pharmacology.

Anti-Vascular Endothelial Growth Factor Treatment in Combination with Chemotherapy Delays Hematopoietic Recovery Due to Decreased Proliferation of Bone Marrow Hematopoietic Progenitor Cells

D. Carbone, E. Harth, S. Novitskiy, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells

I. Biaggioni, A. Biktasova, M. Blackburn, 2011, The Journal of Immunology.

and Immunosuppressive Activity of CD11b Adenosinergic Regulation of the Expansion

I. Biaggioni, A. Biktasova, M. Blackburn, 2011 .

Vascular Endothelial Growth Factor Effects on Nuclear Factor-k B Activation in Hematopoietic Progenitor Cells 1

D. Carbone, T. Oyama, S. Nadaf, 2001 .

Single amino acid substitution in aquaporin 11 causes renal failure.

R. Harris, M. Breyer, K. Ishibashi, 2008, Journal of the American Society of Nephrology : JASN.

Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer

D. Carbone, Y. Adachi, S. Han, 2003, Cancer Gene Therapy.

Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy

D. Carbone, M. Dikov, J. Amann, 2022, Neoplasia.

Promise of Immunotherapy in Lung Cancer.

D. Carbone, M. Dikov, A. Shanker, 2015, Progress in tumor research.

Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation1

D. Carbone, S. Nadaf, J. Ohm, 2005, The Journal of Immunology.

Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.

D. Carbone, Yuhui Huang, M. Dikov, 2011, Cancer research.

Microenvironment and Immunology Resuscitating Cancer Immunosurveillance : Selective Stimulation of DLL 1-Notch Signaling in T cells Rescues T-cell Function and Inhibits Tumor Growth

D. Carbone, Yuhui Huang, M. Dikov, 2011 .

Combination Therapy with Conditionally Replicating Adenovirus and Replication Defective Adenovirus

D. Carbone, S. Nadaf, K. Yanagisawa, 2004, Cancer Research.

Host A(2B) adenosine receptors promote carcinoma growth.

D. Carbone, I. Biaggioni, S. Novitskiy, 2008, Neoplasia.

Vascular Endothelial Growth Factor Effects on Nuclear Factor-κB Activation in Hematopoietic Progenitor Cells

D. Carbone, T. Oyama, S. Nadaf, 2001 .

The Foxc2 transcription factor regulates tumor angiogenesis.

T. Kume, H. Sano, S. Novitskiy, 2010, Biochemical and biophysical research communications.

Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk

D. Carbone, M. Dikov, R. Uzhachenko, 2015, Oncotarget.

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

Jason V. Evans, P. Fadda, D. Carbone, 2018, Nature Communications.

Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.

Jason V. Evans, D. Carbone, A. Biktasova, 2015, Cancer research.

Functional Defects of Dendritic Cells in Cancer

M. Dikov, I. Chekneva, 2009 .

CHAPTER 44 – Vascular endothelial growth factor

D. Gabrilovich, M. Dikov, 2003 .

Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.

D. Carbone, S. Nadaf, J. Ohm, 2002, Gastroenterology.

Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression

Jason V. Evans, M. Dikov, T. Eubank, 2017, Scientific Reports.

Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunity

Jason V. Evans, P. Massion, D. Carbone, 2019, Journal of Immunotherapy for Cancer.

Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity

Jason V. Evans, P. Massion, D. Carbone, 2019, Journal of Immunotherapy for Cancer.

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

D. Carbone, S. Novitskiy, Yuhui Huang, 2007, Blood.

EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia

C. Bloomfield, R. Garzon, Changxian Shen, 2019, Clinical Cancer Research.

Signaling in Mast Cells Ablation on Proinflammatory Adenosine Adenosine Receptor Gene 2B Effect of A

I. Biaggioni, S. Novitskiy, A. Goldstein, 2013 .

Effect of A2B Adenosine Receptor Gene Ablation on Proinflammatory Adenosine Signaling in Mast Cells1

I. Biaggioni, M. Blackburn, S. Novitskiy, 2008, The Journal of Immunology.

Aquaporin 11 variant associates with kidney disease in type 2 diabetic patients.

D. Carbone, R. Harris, M. Dikov, 2016, American journal of physiology. Renal physiology.

Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress.

A. Gow, Natalia Shlonimskaya, R. Harris, 2013, American journal of physiology. Renal physiology.

P2.03b-082 AQP11 as a Novel Factor of Lung Cancer Cell Resistance to Cisplatin: Topic: Biomarkers

Jason V. Evans, D. Carbone, M. Dikov, 2017 .

Abstract 2620: Aquaporin 11 as a new predictive biomarker of overall survival and platinum-based chemotherapy response in lung adenocarcinoma patients

Michael F. Sharpnack, D. Carbone, M. Dikov, 2018, Clinical Research (Excluding Clinical Trials).

Cancer therapy by resuscitating Notch immune surveillance

D. Carbone, M. Dikov, R. Uzhachenko, 2014, Journal of Immunotherapy for Cancer.

Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.

Jason V. Evans, D. Carbone, A. Biktasova, 2015, Cancer research.

Identification of proteolytic fragments from ErbB-2 that induce apoptosis

G. Carpenter, O. Tikhomirov, M. Dikov, 2005, Oncogene.

Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression

Jason V. Evans, D. Carbone, J. Zweier, 2023, Journal of the National Cancer Institute.